01:26
Unknown
Glenmark Pharmaceuticals and Glenmark Generics Inc., USA (Glenmark) has confirmed th
at Cephalon Inc. has filed a patent infringement suit on December 26, 2013 in the US District Court for the District of Delaware seeking to prevent Glenmark from commercializing its Abbreviated New Drug Application (ANDA) Bendamustine Hydrochloride product, their generic version of Treanda, prior to expiration of the Orange Book patents. This lawsuit was filed under the provisions of the Hatch-Waxman Act.
Posted in: Indian Market Tips
0 comments:
Post a Comment